Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06896474 | SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers(SDMPOSSIBLE) | recruiting | N/A | 402 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07424547 | Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors | recruiting | Phase 1 | 386 | Conjupro Biotherapeutics, Inc.INDUSTRY | 1 | Apr 7, 2026 |
| NCT07515326 | Evolution of Clinical and Motivational Constructs During the Physical Activity Program KHEOPS, Already Offered to Patients at the Centre Léon Bérard(CANDY) | recruiting | — | 80 | Centre Leon BerardOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT04022616 | Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients | recruiting | — | 99 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT06547840 | A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha | recruiting | Phase 1 | 45 | Epsilogen LtdINDUSTRY | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07112053 | A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer | recruiting | Phase 2 | 40 | University of WashingtonOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07386444 | Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy(IMACT) | recruiting | N/A | 58 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07510802 | Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC | recruiting | Phase 1 / Phase 2 | 60 | Beijing BiotechINDUSTRY | 1 | Apr 6, 2026 | clinicaltrials |
| NCT06905561 | Topical Diclofenac for Prevention of Radiation-induced Dermatitis | recruiting | N/A | 156 | The Second Affiliated Hospital of Hainan Medical UniversityOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT07426809 | Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study).(MOZART) | recruiting | N/A | 314 | Royal College of Surgeons, IrelandOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT07510698 | Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer(AMADeuS) | recruiting | N/A | 100 | University of Rome Tor VergataOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT04475640 | Cancer Genetic Testing in Ethnic Populations | recruiting | N/A | 1,800 | Mayo ClinicOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05746325 | Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer | recruiting | N/A | 5 | Mayo ClinicOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT06451497 | This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 100 | Zumutor Biologics Inc.INDUSTRY | 1 | Apr 2, 2026 | clinicaltrials |
| NCT07492394 | Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer | recruiting | Phase 2 | 60 | Hebei Medical University Fourth HospitalOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT07507890 | Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer(Mini-B) | recruiting | N/A | 10 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05735080 | Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer(INX-315-01) | recruiting | Phase 1 / Phase 2 | 150 | Incyclix BioINDUSTRY | 2 | Apr 1, 2026 | clinicaltrials |
| NCT05769010 | Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases | recruiting | Phase 2 | 150 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06365788 | Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer(ABBICAR) | recruiting | Phase 2 | 53 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06435351 | Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy | recruiting | Early Phase 1 | 16 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06768931 | Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer | recruiting | Phase 2 | 192 | Sun Yat-sen UniversityOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06953245 | Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy | recruiting | — | 20 | Mayo ClinicOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT07074106 | TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC(DespaTIL) | recruiting | Phase 2 | 40 | D'Or Institute for Research and EducationOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT07455955 | Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile | recruiting | Phase 2 | 200 | Chinese University of Hong KongOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT04654208 | Swedish Ibrance Registries Insights (SIRI)(SIRI) | recruiting | — | 1,500 | PfizerINDUSTRY | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05417867 | Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer | recruiting | — | 70 | Mayo ClinicOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT05981326 | Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients(NEOEPICURE) | recruiting | N/A | 300 | Institut Cancerologie de l'OuestOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT06450873 | Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery | recruiting | Phase 2 | 40 | Mayo ClinicOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT06954961 | A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer | recruiting | Phase 3 | 640 | InventisBio Co., LtdINDUSTRY | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07289282 | Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer(miRNA-NAC) | recruiting | — | 80 | Atlas UniversityOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07503496 | Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy | recruiting | N/A | 96 | China Medical University HospitalOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07503704 | A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived From Cerebrospinal Fluid (CSF)(PRIMROSE) | recruiting | — | 69 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07503717 | SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance(SURVEY-CNS) | recruiting | N/A | 69 | Royal College of Surgeons, IrelandOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07504367 | Large Language Models Assist in Tumor MDT | recruiting | N/A | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT03449238 | Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients | recruiting | Phase 1 / Phase 2 | 41 | Weill Medical College of Cornell UniversityOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT04109079 | Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy(ATNEC) | recruiting | N/A | 1,900 | University Hospitals of Derby and Burton NHS Foundation TrustOTHER | 2 | Mar 30, 2026 | clinicaltrials |
| NCT06927895 | Breast Cancer Implementation Science Study With Educational Intervention | recruiting | N/A | 30 | NYU Langone HealthOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT02610413 | Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer | recruiting | — | 354 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2026 | clinicaltrials |
| NCT02610426 | Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer | recruiting | — | 162 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2026 | clinicaltrials |
| NCT02610439 | Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer | recruiting | — | 575 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2026 | clinicaltrials |
| NCT05142033 | Avera Cancer Sequencing and Analytics Protocol (ASAP)(ASAP) | recruiting | — | 25,000 | Avera McKennan Hospital & University Health CenterOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06395519 | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies(ERADIC8) | recruiting | Phase 1 / Phase 2 | 120 | 858 Therapeutics, Inc.INDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06906237 | Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study(ScarABEO) | recruiting | — | 250 | Istituto Oncologico Veneto IRCCSOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07043725 | A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | recruiting | Phase 3 | 544 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07327970 | Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer(ATARAXIS NEOP) | recruiting | — | 150 | Young-Joon KangOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07371585 | Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management(TOP-REAL) | recruiting | Phase 2 | 300 | SOLTI Breast Cancer Research GroupOTHER | 3 | Mar 27, 2026 | clinicaltrials |
| NCT07498478 | Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment | recruiting | Phase 2 | 94 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07498855 | Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation(RADIANT) | recruiting | — | 25 | Ruijin HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT05806060 | Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer(BCTOP-T-M01) | recruiting | Phase 3 | 134 | Fudan UniversityOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07492589 | Photo-Acoustic and Ultrasonographic Mammoscope(PAUS) | recruiting | Phase 2 | 180 | Franciscus Gasthuis & Vlietland (Hospital)OTHER | 1 | Mar 25, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Apr 7, 2026source: clinicaltrials